Carasent: Webdoc NO a Litmus Test for Carasent’s Extensive Capex Initiatives - Redeye
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Aktieanalys

Carasent: Webdoc NO a Litmus Test for Carasent’s Extensive Capex Initiatives - Redeye

{newsItem.title}

Redeye updates its estimates following Carasent’s Q1 report and comments on topics ranging from the heavy capex cycle to CEO Dennis Höjer’s decision to step down. We expect Webdoc NO to be launched in Q2 2022 and its launch and successive ramp-up will be a litmus test for the Webdoc platform and the current spending levels.

Länk till analysen i sin helhet: https://www.redeye.se/research/842767/carasent-webdoc-no-a-litmus-test-for-carasents-extensive-capex-initiatives?utm_source=finwire&utm_medium=RSS

Nyheter om Carasent

Läses av andra just nu

Om aktien Carasent

Senaste nytt